St. Johns Investment Management’s Novo Nordisk NVO Stock Holding History

St. Johns Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.4K	Hold	38	–	–	﹤0.01%	181
2025 Q4	$1.93K	Hold	38	–	–	﹤0.01%	171
2025 Q3	$2.11K	Hold	38	–	–	﹤0.01%	172
2025 Q2	$2.62K	Hold	38	–	–	﹤0.01%	163
2025 Q1	$2.64K	Hold	38	–	–	﹤0.01%	150
2024 Q4	$3.27K	Hold	38	–	–	﹤0.01%	153
2024 Q3	$4.53K	Hold	38	–	–	﹤0.01%	161
2024 Q2	$5.42K	Hold	38	–	–	﹤0.01%	140
2024 Q1	$4.88K	Buy	+38	New	+$4.52K	﹤0.01%	154

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

St. Johns Investment Management's NVO Position: Q1 2026 in Review

St. Johns Investment Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 38 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #181.

St. Johns Investment Management first reported a position in NVO in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.42K in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

St. Johns Investment Management held 38 shares of Novo Nordisk worth $1.4K as of Q1 2026.
St. Johns Investment Management left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up ﹤0.01% of St. Johns Investment Management's portfolio in Q1 2026, its #181 holding.
St. Johns Investment Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 9 quarters since.
St. Johns Investment Management's Novo Nordisk position peaked at $5.42K in Q2 2024.
1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on St. Johns Investment Management's 13F filing for Q1 2026, filed 28 Apr 2026.